IP Library › Patent Application 63009155
Patent Application Provisional
App. No. 63/009,155 · Confirmation No. 5160

ACTIVATING ENDOGENOUS ANTIMICROBIALS TO TREAT SARS-COV-2 INFECTION

Applicant: EIRGEN PHARMA LTD.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2021-03-31 APP.FILE.REC Filing Receipt 3 View
2021-03-31 R48.REQ.G Acceptance of Request under Rule 48 to correct inventorship or name 1 View
2021-03-31 APP.FILE.REC Filing Receipt 3 View
2021-03-29 R48.REQ Request under Rule 48 correcting inventorship 2 View
2021-03-29 R3.73 Assignee showing of ownership per 37 CFR 3.73 2 View
2021-03-29 R46C.REQ Request under 37CFR1.46(c) to correct, update, change applicant 1 View
2021-03-29 R3.73 Assignee showing of ownership per 37 CFR 3.73 15 View
2021-03-29 WFEE Fee Worksheet (SB06) 2 View
2021-03-29 N417 Electronic Filing System Acknowledgment Receipt 3 View
2021-03-29 ADS Application Data Sheet 6 View
2020-05-06 APP.FILE.REC Filing Receipt 3 View
2020-05-04 CFILE Request for Corrected Filing Receipt 1 View
2020-05-04 ADS Application Data Sheet 4 View
2020-05-04 N417 Electronic Filing System Acknowledgment Receipt 2 View
2020-04-27 APP.FILE.REC Filing Receipt 3 View
2020-04-13 ADS Application Data Sheet 4 View
2020-04-13 TR.PROV Provisional Cover Sheet (SB16) 2 View
2020-04-13 DRW Drawings-only black and white line drawings 15 View
2020-04-13 WFEE Fee Worksheet (SB06) 2 View
2020-04-13 N417 Electronic Filing System Acknowledgment Receipt 3 View
2020-04-13 SPEC Specification 36 View
2020-04-13 CLM Claims 11 View
2020-04-13 ABST Abstract 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/009,155
Filed
2020-04-13